Transmitter-induced changes of the membrane voltage of HT29 cells

E Lohrmann1, Z I Cabantchik, R Greger

  • 1Physiologisches Institut der Albert-Ludwigs-Universität Freiburg, Federal Republic of Germany.

Insights

This study investigated how various substances affect the membrane voltage of HT29 colon cancer cells. Key findings show that cAMP-increasing agents and nucleotides depolarize these cells, impacting cell function.

Area of Science:

  • Cellular Electrophysiology
  • Colorectal Cancer Research

Background:

  • The HT29 colon carcinoma cell line is a model for studying cellular responses.
  • Understanding ion channel activity and membrane potential is crucial for cancer cell biology.

Purpose of the Study:

  • To investigate the effects of agonists that increase cytosolic cyclic adenosine monophosphate (cAMP) and calcium (Ca2+) activity on HT29 cell membrane voltage (Vm).
  • To characterize the changes in membrane potential induced by various signaling molecules.

Main Methods:

  • Utilized microelectrode impalement to measure the membrane voltage (Vm) of HT29 cells grown on glass coverslips.
  • Applied various ionic solutions (varying K+, Cl-, osmolarity) and agonists (cAMP inducers, nucleotides, carbachol, neurotensin) to assess their impact on Vm.

Main Results:

  • Increased extracellular K+ or Ba2+ caused depolarization. Decreased extracellular Cl- also led to depolarization.
  • Agents that increase intracellular cAMP, such as forskolin and isobutylmethylxanthine, depolarized the cells.
  • Purine and pyrimidine nucleotides, particularly UTP and ATP, dose-dependently depolarized HT29 cells. Carbachol and neurotensin also induced significant depolarization.

Conclusions:

  • Various signaling pathways involving cAMP, Ca2+, and specific agonists modulate the membrane potential of HT29 colon cancer cells.
  • These findings provide insights into the electrophysiological properties of colon cancer cells and potential therapeutic targets.